See also this year's filing and all EDGAR filings for this company.
PDF Report 0001311241_2016_Intermolecular_INC.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| warning | No stock price available | subcommand.plot | {} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('EntityCommonStockSharesOutstanding')"} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001311241')"} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('EntityCommonStockSharesOutstanding')"} |
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0001311241, Intermolecular INC
| xvar | xval | |
|---|---|---|
| 0 | LiabilitiesCurrent | 10,244,000 |
| 1 | LiabilitiesNonCurrent | 35,000 |
| 2 | remainder_Liabilities | 3,299,000 |
| 3 | AssetsCurrent | 43,054,000 |
| 4 | AssetsNonCurrent | 506,000 |
| 5 | IntangibleAssets | 5,969,000 |
| 6 | PropertyPlantAndEquipmentNet | 15,735,000 |
| 7 | remainder_Assets | 4,413,000 |
| 8 | ResearchAndDevelopmentExpense | 28,576,000 |
| 9 | SellingGeneralAndAdministrativeExpense | 18,168,000 |
| 10 | AmortizationOfIntangibleAssets | 0 |
| 11 | remainder_Expenses | 19,312,000 |
| 12 | remainder_Revenues | 45,322,000 |
| 13 | remainder_NetIncome | -279,000 |
| 14 | remainder_ComprehensiveNetIncome | 13,000 |
| yvar | yval | |
|---|---|---|
| 0 | Liabilities | 13,578,000 |
| 1 | Assets | 69,677,000 |
| 2 | Expenses | 66,056,000 |
| 3 | Revenues | 45,322,000 |
| 4 | StockholdersEquity | 56,099,000 |
| 5 | NetIncome | -21,013,000 |
| 6 | ComprehensiveNetIncome | -21,000,000 |
| 7 | BaseVar | 255,475,550 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 1.22 |
| 9 | EconomicCapitalRatio | 1.52 |
Edgar->Model Mapping
Feature Distribution
Change over Time
